INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $863,732 | -21.1% | 27,316 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $1,094,780 | +8.6% | 26,846 | -0.8% | 0.00% | 0.0% |
| Q1 2023 | $1,008,377 | +14.3% | 27,056 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $882,543 | -38.9% | 25,295 | -2.1% | 0.00% | -50.0% |
| Q3 2022 | $1,445,000 | -1.2% | 25,828 | -8.6% | 0.00% | 0.0% |
| Q2 2022 | $1,463,000 | -96.5% | 28,265 | -95.2% | 0.00% | -95.2% |
| Q1 2022 | $42,017,000 | -43.4% | 587,931 | -6.3% | 0.04% | -38.2% |
| Q4 2021 | $74,195,000 | -28.1% | 627,497 | -18.4% | 0.07% | -32.7% |
| Q3 2021 | $103,222,000 | +62.0% | 769,456 | +95.5% | 0.10% | +65.6% |
| Q2 2021 | $63,715,000 | +1880.0% | 393,523 | +881.5% | 0.06% | +1933.3% |
| Q1 2021 | $3,218,000 | +66.2% | 40,095 | +12.7% | 0.00% | +50.0% |
| Q4 2020 | $1,936,000 | +160.6% | 35,592 | -4.8% | 0.00% | +100.0% |
| Q3 2020 | $743,000 | +462.9% | 37,385 | +244.7% | 0.00% | – |
| Q1 2020 | $132,000 | +5.6% | 10,846 | +27.4% | 0.00% | – |
| Q4 2019 | $125,000 | +86.6% | 8,514 | +69.6% | 0.00% | – |
| Q3 2019 | $67,000 | – | 5,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |